Redsense Medical Investor Relations Material

Redsense Medical AB specializes in enhancing patient safety within the hemodialysis sector through its innovative monitoring systems. The company has developed a unique solution that utilizes patented fiber optic technology to detect the first sign of a blood leak, such as venous needle dislodgement (VND) and catheter leakage, promptly triggering an alarm. This technology meets the safety demands of healthcare providers, offering features like easy one-button operation and compatibility with venous needle or catheter access. The company is headquartered in Halmstad, Sweden, and its shares are listed on the Stockholm Stock Exchange.